arrow
T

Toby N. Trahair

UNSW
H指数:40
被引数:5,070

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Precision-guided therapy in H3K27-altered diffuse midline glioma

H3K27-改变的弥漫性中线胶质瘤中的精准导向疗法

2026-05-190
OAAI
Blinatumomab in de novo AYA ALL—Results of the Australasian Leukaemia and Lymphoma Group ALL09 “SUBLIME” study
2026-01-230
OAAI
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma

在多药联合化疗中加入JNK非依赖性药物可改善复发高风险神经母细胞瘤的治疗反应

2025-11-280
PRE
Measurable residual disease detection in acute lymphoblastic leukaemia: comparison between targeted next-generation sequencing and allele-specific oligonucleotide real-time quantitative polymerase chain reaction

急性淋巴细胞白血病的可测量残留病灶检测:靶向下一代测序与等位基因特异性寡核苷酸实时定量聚合酶链反应的比较

2025-11-250
PRE
P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma
2025-11-010
OA
Harmonization of reporting for detection of ALK genetic alterations in neuroblastoma - a SIOPEN Biology study

神经母细胞瘤ALK基因改变检测报告的标准化——一项SIOPEN生物学研究

2025-10-170
PRE
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds

超增强子驱动的长链非编码RNA PRKCQ-AS1通过与其SI2蛋白相互作用促进神经母细胞瘤肿瘤发生,且可被小分子化合物靶向。

2025-03-180
OAAI
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma

铜螯合改变中性粒细胞功能以增强神经母细胞瘤的anti-GD2抗体治疗

2024-12-120
OAAI
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia
2024-11-060
OAAI
Health-Related Quality of Life in Adolescents and Young Adults Treated with Blinatumomab Consolidation for CD19+Ph-Negative Acute Lymphoblastic Leukemia in the Australasian Lymphoma and Leukaemia Group (ALLG) ALL09 Sublime Study

与健康相关的生活质量:在Australasian Lymphoma and Leukaemia Group (ALLG) ALL09 Sublime研究中,接受Blinatumomab巩固治疗的CD19+Ph-急性淋巴细胞白血病的青少年和年轻成年患者

BLOOD
IF23.1
2024-11-050
PRE
Implementing ultra-sensitive, ctDNA-based liquid biopsy for disease monitoring in paediatric tumours
2024-09-050
PRE
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024-07-051
OAAI
PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA
2024-06-180
OAAI
Precision-guided treatment in high-risk pediatric cancers
2024-06-067
OAAI
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults
2024-01-316
OAAI
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer

原发性肿瘤细胞的高通量药物筛选确定治疗高危癌症儿童的治疗策略

2023-07-3114
OAAI